Xuefei Sun

发表

Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis

Zixing Deng, Ruonan Li, Yuchen Wu, 2022, Cancer Immunology, Immunotherapy.

Expression of hypoxia‐inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors

N. Ji, Shengjun Sun, W. Lai, 2020, Brain and behavior.

Isolated primary intracranial myeloid sarcoma with neuromeningeal infiltration: A case report

Chen Wang, Q. Cui, Hong Zhu, 2015, Oncology letters.

Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma

X. Qiu, N. Ji, Shengjun Sun, 2017, Oncotarget.

Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.

Zhenkun Yu, N. Ji, Shengjun Sun, 2017, Oncology letters.

The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis

G. Dong, Shengjun Sun, Xiaowei Zhang, 2022, BMC cancer.

Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China

Shengjun Sun, W. Lai, Yuedan Chen, 2022, Frontiers in Oncology.

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis

Yuedan Chen, Q. Cui, L. Lv, 2021, Frontiers in Oncology.

Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis

Zixing Deng, L. Lv, Xuefei Sun, 2022, Cancer Immunology, Immunotherapy.

Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

Chun-ji Gao, Jia-zhen Guo, Jing Liu, 2022, Frontiers in Oncology.

Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases.

Yajie Wang, Zhe Liu, Bingxu Wang, 2017, Oncology letters.

The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis

G. Dong, Shengjun Sun, Q. Cui, 2021, BMC Cancer.

STAT3 activation is associated with IL-10 expression and survival in primary central nervous system lymphoma.

N. Ji, Shengjun Sun, Yuedan Chen, 2019, World neurosurgery.

Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.

Yajie Wang, N. Ji, Shengjun Sun, 2017, Oncology reports.

Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

N. Ji, Shengjun Sun, W. Lai, 2021, Chinese Neurosurgical Journal.

Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature

Yuedan Chen, Jing Liu, Xuefei Sun, 2018, Chinese Neurosurgical Journal.

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict chemotherapeutic responses and survival in primary central-nervous-system lymphoma

Y. Shan, Jie Lu, N. Ji, 2020, European Radiology.

Challenges in the management of primary central nervous system lymphoma.

Shengjun Sun, Q. Cui, L. Lv, 2023, Critical reviews in oncology/hematology.

Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population

N. Ji, Shengjun Sun, Yuedan Chen, 2019, BMC Neurology.

Management of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center experience

N. Ji, Shengjun Sun, W. Lai, 2020 .